Skip to main content
Top
Published in: Journal of Translational Medicine 1/2019

Open Access 01-12-2019 | Colorectal Cancer | Research

Direct S-Poly(T) Plus assay in quantification of microRNAs without RNA extraction and its implications in colorectal cancer biomarker studies

Authors: Yanqin Niu, Sijian Xia, Mingyang Su, Quanjin Dang, Kang Kang, Li Li, Deming Gou

Published in: Journal of Translational Medicine | Issue 1/2019

Login to get access

Abstract

Background

Advances in microRNAs (miRNAs) biomarkers have generated disease markers with potential clinical values. However, none of these published results have been applied in clinic until today. The main reason could be the lack of simple but robust miRNA measurements.

Methods

We built up a simple but ultrasensitive RT-qPCR protocol, Direct S-Poly(T) Plus assay, for detecting miRNAs without RNA purification. In this study, the method was optimized and compared with other RNA purification-based miRNA assays, and the sensitivity was tested. Using Direct S-Poly(T) Plus method, seven potential miRNA biomarkers of colorectal cancer were validated.

Results

It is possible to detect approximately 100 miRNAs with minimal plasma inputs (20 μl) and time (~ 140 min) with this approach. The sensitivity of this method was 2.7–343-fold higher than that of the stem-loop method, and comparable with S-Poly(T) plus method. 7 validated miRNA biomarkers of colorectal cancer by Direct S-Poly(T) plus assay could discriminate colorectal cancer stage I from healthy individuals, and promised satisfactory discrimination with the area under receiver operating characteristic (ROC) curve ranging from 0.79 to 0.94 (p value < 0.001).

Conclusions

This simple and robust protocol may have strong impact on the development of specific miRNAs as biomarkers in clinic.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–97.CrossRef Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–97.CrossRef
2.
go back to reference He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5(7):522–31.CrossRef He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5(7):522–31.CrossRef
3.
go back to reference Lim LP, Glasner ME, Yekta S, Burge CB, Bartel DP. Vertebrate microRNA genes. Science. 2003;299(5612):1540.CrossRef Lim LP, Glasner ME, Yekta S, Burge CB, Bartel DP. Vertebrate microRNA genes. Science. 2003;299(5612):1540.CrossRef
4.
go back to reference Bushati N, Cohen SM. microRNA functions. Ann Rev Cell Dev Biol. 2007;23:175–205.CrossRef Bushati N, Cohen SM. microRNA functions. Ann Rev Cell Dev Biol. 2007;23:175–205.CrossRef
5.
go back to reference Chen J-F, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006;38(2):228–33.CrossRef Chen J-F, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006;38(2):228–33.CrossRef
6.
go back to reference Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol. 2009;112(1):55–9.CrossRef Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol. 2009;112(1):55–9.CrossRef
7.
go back to reference Shimomura A, Shiino S, Kawauchi J, Takizawa S, Sakamoto H, Matsuzaki J, et al. Novel combination of serum microRNA for detecting breast cancer in the early stage. Cancer Sci. 2016;107(3):326–34.CrossRef Shimomura A, Shiino S, Kawauchi J, Takizawa S, Sakamoto H, Matsuzaki J, et al. Novel combination of serum microRNA for detecting breast cancer in the early stage. Cancer Sci. 2016;107(3):326–34.CrossRef
8.
go back to reference Dimmeler S, Zeiher AM. Circulating microRNAs: novel biomarkers for cardiovascular diseases? Eur Heart J. 2010;31(22):2705–7.CrossRef Dimmeler S, Zeiher AM. Circulating microRNAs: novel biomarkers for cardiovascular diseases? Eur Heart J. 2010;31(22):2705–7.CrossRef
9.
go back to reference Kosaka N, Izumi H, Sekine K, Ochiya T. microRNA as a new immune-regulatory agent in breast milk. Silence. 2010;1(1):1.CrossRef Kosaka N, Izumi H, Sekine K, Ochiya T. microRNA as a new immune-regulatory agent in breast milk. Silence. 2010;1(1):1.CrossRef
10.
go back to reference Hanke M, Hoefig K, Merz H, Feller AC, Kausch I, Jocham D, et al., editors. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. In: Urologic oncology. vol. 28, No. 6. pp. 0–661. 2010. Hanke M, Hoefig K, Merz H, Feller AC, Kausch I, Jocham D, et al., editors. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. In: Urologic oncology. vol. 28, No. 6. pp. 0–661. 2010.
11.
go back to reference Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56(11):1733–41.CrossRef Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56(11):1733–41.CrossRef
12.
go back to reference Kang K, Xiaoying Z, Hongtao L, Zhiwei W, Jiasheng Z, Zhenting H, et al. A novel real-time PCR assay of microRNAs using S-Poly(T), a specific oligo(dT) reverse transcription primer with excellent sensitivity and specificity. PLoS ONE. 2012;7(11):e48536.CrossRef Kang K, Xiaoying Z, Hongtao L, Zhiwei W, Jiasheng Z, Zhenting H, et al. A novel real-time PCR assay of microRNAs using S-Poly(T), a specific oligo(dT) reverse transcription primer with excellent sensitivity and specificity. PLoS ONE. 2012;7(11):e48536.CrossRef
13.
go back to reference Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci. 2011;108(12):5003–8.CrossRef Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci. 2011;108(12):5003–8.CrossRef
14.
go back to reference Zhang WC, Chin TM, Yang H, Nga ME, Lunny DP, Lim EKH, et al. Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression. Nat Commun. 2016;7:11702.CrossRef Zhang WC, Chin TM, Yang H, Nga ME, Lunny DP, Lim EKH, et al. Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression. Nat Commun. 2016;7:11702.CrossRef
15.
go back to reference Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010;101(10):2087–92.CrossRef Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010;101(10):2087–92.CrossRef
16.
go back to reference Pu X, Gu J, Ye Y, Ajani J, Wu X. Circulating miRNAs as potential biomarkers for esophageal adenocarcinoma risk and clinical outcomes. Cancer Res. 2014;74(19 Supplement):2915. Pu X, Gu J, Ye Y, Ajani J, Wu X. Circulating miRNAs as potential biomarkers for esophageal adenocarcinoma risk and clinical outcomes. Cancer Res. 2014;74(19 Supplement):2915.
17.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRef Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRef
18.
go back to reference Wang S, Xiang J, Li Z, Lu S, Hu J, Gao X, et al. A plasma microRNA panel for early detection of colorectal cancer. Int J Cancer. 2015;136(1):152–61.CrossRef Wang S, Xiang J, Li Z, Lu S, Hu J, Gao X, et al. A plasma microRNA panel for early detection of colorectal cancer. Int J Cancer. 2015;136(1):152–61.CrossRef
19.
go back to reference Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer. 2010;127(1):118–26.CrossRef Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer. 2010;127(1):118–26.CrossRef
20.
go back to reference Ng EK, Chong WW, Lam EK, Shin VY, Yu J, Poon TC, et al. Differential expression of microRNAs in plasma of colorectal cancer patients: a potential marker for colorectal cancer screening. Gut. 2009;136(5):1375–81.CrossRef Ng EK, Chong WW, Lam EK, Shin VY, Yu J, Poon TC, et al. Differential expression of microRNAs in plasma of colorectal cancer patients: a potential marker for colorectal cancer screening. Gut. 2009;136(5):1375–81.CrossRef
21.
go back to reference Zhang J, Raju GS, Chang DW, Lin SH, Chen Z, Wu X. Global and targeted circulating microrna profiling of colorectal adenoma and colorectal cancer. Cancer. 2017;124(4):785–96.CrossRef Zhang J, Raju GS, Chang DW, Lin SH, Chen Z, Wu X. Global and targeted circulating microrna profiling of colorectal adenoma and colorectal cancer. Cancer. 2017;124(4):785–96.CrossRef
22.
go back to reference Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut. 2009;58(10):1375–81.CrossRef Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut. 2009;58(10):1375–81.CrossRef
23.
go back to reference Wang S, Liu X, Pan B, Sun L, Chen X, Zeng K, et al. Circulating exosomal miR-27a and miR-130a act as novel diagnostic and prognostic biomarkers of colorectal cancer. Cancer Epidemiol Biomarkers. 2018;27(7):746–54.CrossRef Wang S, Liu X, Pan B, Sun L, Chen X, Zeng K, et al. Circulating exosomal miR-27a and miR-130a act as novel diagnostic and prognostic biomarkers of colorectal cancer. Cancer Epidemiol Biomarkers. 2018;27(7):746–54.CrossRef
24.
go back to reference Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;33(20):e179.CrossRef Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;33(20):e179.CrossRef
25.
go back to reference Niu Y, Zhang L, Qiu H, Wu Y, Wang Z, Zai Y, et al. An improved method for detecting circulating microRNAs with S-Poly (T) Plus real-time PCR. Sci Rep. 2015;5:15100.CrossRef Niu Y, Zhang L, Qiu H, Wu Y, Wang Z, Zai Y, et al. An improved method for detecting circulating microRNAs with S-Poly (T) Plus real-time PCR. Sci Rep. 2015;5:15100.CrossRef
26.
go back to reference Kang K, Yang K, Zhong J, Tian Y, Zhang L, Zhai J, et al. A direct real-time polymerase chain reaction assay for rapid high-throughput detection of highly pathogenic north american porcine reproductive and respiratory syndrome virus in china without rna purification. J Anim Sci Biotechnol. 2014;5(1):45.CrossRef Kang K, Yang K, Zhong J, Tian Y, Zhang L, Zhai J, et al. A direct real-time polymerase chain reaction assay for rapid high-throughput detection of highly pathogenic north american porcine reproductive and respiratory syndrome virus in china without rna purification. J Anim Sci Biotechnol. 2014;5(1):45.CrossRef
27.
go back to reference Niu Y, Wu Y, Huang J, Li Q, Kang K, Qu J, et al. Identification of reference genes for circulating microRNA analysis in colorectal cancer. Sci Rep. 2016;6:35611.CrossRef Niu Y, Wu Y, Huang J, Li Q, Kang K, Qu J, et al. Identification of reference genes for circulating microRNA analysis in colorectal cancer. Sci Rep. 2016;6:35611.CrossRef
28.
go back to reference Asaga S, Kuo C, Nguyen T, Terpenning M, Giuliano AE, Hoon DS. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem. 2011;57(1):84–91.CrossRef Asaga S, Kuo C, Nguyen T, Terpenning M, Giuliano AE, Hoon DS. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem. 2011;57(1):84–91.CrossRef
29.
go back to reference Zhao Q, Deng S, Wang G, Liu C, Meng L, Qiao S, et al. A direct quantification method for measuring plasma MicroRNAs identified potential biomarkers for detecting metastatic breast cancer. Oncotarget. 2016;7(16):21865.CrossRef Zhao Q, Deng S, Wang G, Liu C, Meng L, Qiao S, et al. A direct quantification method for measuring plasma MicroRNAs identified potential biomarkers for detecting metastatic breast cancer. Oncotarget. 2016;7(16):21865.CrossRef
30.
go back to reference Kermekchiev MB, Tzekov A, Barnes WM. Cold-sensitive mutants of Taq DNA polymerase provide a hot start for PCR. Nucleic Acids Res. 2003;31(21):6139–47.CrossRef Kermekchiev MB, Tzekov A, Barnes WM. Cold-sensitive mutants of Taq DNA polymerase provide a hot start for PCR. Nucleic Acids Res. 2003;31(21):6139–47.CrossRef
31.
go back to reference Kellogg D, Rybalkin I, Chen S, Mukhamedova N, Vlasik T, Siebert P, et al. TaqStart Antibody:” hot start” PCR facilitated by a neutralizing monoclonal antibody directed against Taq DNA polymerase. Biotechniques. 1994;16(6):1134–7.PubMed Kellogg D, Rybalkin I, Chen S, Mukhamedova N, Vlasik T, Siebert P, et al. TaqStart Antibody:” hot start” PCR facilitated by a neutralizing monoclonal antibody directed against Taq DNA polymerase. Biotechniques. 1994;16(6):1134–7.PubMed
32.
go back to reference Ho YK, Xu WT, Too HP. Direct quantification of mRNA and miRNA from cell lysates using reverse transcription real time PCR: a multidimensional analysis of the performance of reagents and workflows. PLoS ONE. 2013;8(9):e72463.CrossRef Ho YK, Xu WT, Too HP. Direct quantification of mRNA and miRNA from cell lysates using reverse transcription real time PCR: a multidimensional analysis of the performance of reagents and workflows. PLoS ONE. 2013;8(9):e72463.CrossRef
34.
go back to reference Herreros-Villanueva M, Duran-Sanchon S, Martin AC, Perez-Palacios R, Vila-Navarro E, Marcuello M, et al. Plasma MicroRNA signature validation for early detection of colorectal cancer. Clin Transl Gastroenterol. 2019;10(1):1–9.CrossRef Herreros-Villanueva M, Duran-Sanchon S, Martin AC, Perez-Palacios R, Vila-Navarro E, Marcuello M, et al. Plasma MicroRNA signature validation for early detection of colorectal cancer. Clin Transl Gastroenterol. 2019;10(1):1–9.CrossRef
36.
go back to reference Bianchi F, Nicassio F, Marzi M, Belloni E, Dall’olio V, Bernard L, et al. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med. 2011;3(8):495–503.CrossRef Bianchi F, Nicassio F, Marzi M, Belloni E, Dall’olio V, Bernard L, et al. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med. 2011;3(8):495–503.CrossRef
37.
go back to reference Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci. 2011;108(9):3713–8.CrossRef Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci. 2011;108(9):3713–8.CrossRef
38.
go back to reference Niu Y, Su M, Wu Y, Fu L, Kang K, Li Q, et al. Circulating plasma miRNAs as potential biomarkers of non-small cell lung cancer obtained by high-throughput real-time PCR profiling. Cancer Epidemiol Biomarkers. 2019;28(2):327–36.CrossRef Niu Y, Su M, Wu Y, Fu L, Kang K, Li Q, et al. Circulating plasma miRNAs as potential biomarkers of non-small cell lung cancer obtained by high-throughput real-time PCR profiling. Cancer Epidemiol Biomarkers. 2019;28(2):327–36.CrossRef
Metadata
Title
Direct S-Poly(T) Plus assay in quantification of microRNAs without RNA extraction and its implications in colorectal cancer biomarker studies
Authors
Yanqin Niu
Sijian Xia
Mingyang Su
Quanjin Dang
Kang Kang
Li Li
Deming Gou
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2019
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-019-2061-6

Other articles of this Issue 1/2019

Journal of Translational Medicine 1/2019 Go to the issue